
    
      The study consisted of 3 Periods: Period 1: a 1-week Screening Phase, Period 2: a 30-week
      Treatment Phase (consisting of a 6-week Titration Phase and a 24-week Maintenance Phase), and
      Period 3: a 3-week Taper/Safety Follow-Up Phase.
    
  